Ridgeback Biotherapeutics
Founded
2016
2016
Clinical Trials
4
4
Publications
12
12
Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions.
Get access to BPT Crunch to view additional information about this company